Adaptive therapy: a tumor therapy strategy based on Darwinian evolution theory
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adaptive therapy: a tumor therapy strategy based on Darwinian evolution theory
Authors
Keywords
-
Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume -, Issue -, Pages 104192
Publisher
Elsevier BV
Online
2023-10-28
DOI
10.1016/j.critrevonc.2023.104192
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evolution-based mathematical models significantly prolong response to abiraterone in metastatic castrate-resistant prostate cancer and identify strategies to further improve outcomes
- (2022) Jingsong Zhang et al. eLife
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Adaptive Therapy for Metastatic Melanoma: Predictions from Patient Calibrated Mathematical Models
- (2021) Eunjung Kim et al. Cancers
- Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review
- (2021) Alessandro Leonetti et al. Frontiers in Oncology
- A theoretical analysis of tumour containment
- (2021) Yannick Viossat et al. Nature Ecology & Evolution
- Predicting patient-specific response to adaptive therapy in metastatic castration-resistant prostate cancer using prostate-specific antigen dynamics
- (2021) Renee Brady-Nicholls et al. NEOPLASIA
- Are Adaptive Chemotherapy Schedules Robust? A Three-Strategy Stochastic Evolutionary Game Theory Model
- (2021) Rajvir Dua et al. Cancers
- Darwinian Approaches for Cancer Treatment: Benefits of Mathematical Modeling
- (2021) Sophia Belkhir et al. Cancers
- Optimizing Adaptive Therapy Based on the Reachability to Tumor Resistant Subpopulation
- (2021) Jiali Wang et al. Cancers
- Towards Multidrug Adaptive Therapy
- (2020) Jeffrey West et al. CANCER RESEARCH
- Cancer therapy: attempt cure or manage drug resistance?
- (2020) Elsa Hansen et al. Evolutionary Applications
- Mechanisms of Multidrug Resistance in Cancer Chemotherapy
- (2020) Karol Bukowski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures
- (2020) Robert Vander Velde et al. Nature Communications
- Integrating evolutionary dynamics into cancer therapy
- (2020) Robert A. Gatenby et al. Nature Reviews Clinical Oncology
- Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial
- (2020) Alain P. Algazi et al. NATURE MEDICINE
- Optimal control to reach eco-evolutionary stability in metastatic castrate-resistant prostate cancer
- (2020) Jessica Cunningham et al. PLoS One
- Modifying Adaptive Therapy to Enhance Competitive Suppression
- (2020) Elsa Hansen et al. Cancers
- Multidrug cancer therapy in metastatic castrate-resistant prostate cancer: An evolution-based strategy
- (2019) Jeffrey B West et al. CLINICAL CANCER RESEARCH
- Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma
- (2019) Inna Smalley et al. EBioMedicine
- Is There an Independent Role of TERT and NF1 in High Grade Gliomas?
- (2019) Evangelia Razis et al. Translational Oncology
- Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies
- (2018) Jill A. Gallaher et al. CANCER RESEARCH
- Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel
- (2018) Lauren C. Harshman et al. JOURNAL OF CLINICAL ONCOLOGY
- Capitalizing on competition: An evolutionary model of competitive release in metastatic castration resistant prostate cancer treatment
- (2018) Jeffrey West et al. JOURNAL OF THEORETICAL BIOLOGY
- Optimal Control to Develop Therapeutic Strategies for Metastatic Castrate Resistant Prostate Cancer
- (2018) Jessica J. Cunningham et al. JOURNAL OF THEORETICAL BIOLOGY
- Optimizing Cancer Treatment Using Game Theory
- (2018) Katerina Stanková et al. JAMA Oncology
- Is adaptive therapy natural?
- (2018) Frédéric Thomas et al. PLOS BIOLOGY
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Resource limitation prevents the emergence of drug resistance by intensifying within-host competition
- (2017) Nina Wale et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
- (2017) Jingsong Zhang et al. Nature Communications
- Spatial competition constrains resistance to targeted cancer therapy
- (2017) Katarina Bacevic et al. Nature Communications
- Homeostasis Back and Forth: An Ecoevolutionary Perspective of Cancer
- (2017) David Basanta et al. Cold Spring Harbor Perspectives in Medicine
- The Evolution and Ecology of Resistance in Cancer Therapy
- (2017) Robert Gatenby et al. Cold Spring Harbor Perspectives in Medicine
- How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient
- (2017) Elsa Hansen et al. PLOS BIOLOGY
- Histological transformation of ALK rearranged adenocarcinoma into small cell lung cancer: A new mechanism of resistance to ALK inhibitors
- (2016) Delphine Levacq et al. LUNG CANCER
- Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer
- (2016) Pedro M. Enriquez-Navas et al. Science Translational Medicine
- Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival
- (2016) Luc G.T. Morris et al. Oncotarget
- Tumor Molecular Imaging with Nanoparticles
- (2016) Zhen Cheng et al. Engineering
- Quantifying Competitive Exclusion and Competitive Release in Ecological Communities: A Conceptual Framework and a Case Study
- (2016) Hila Segre et al. PLoS One
- Application of Evolutionary Principles to Cancer Therapy
- (2015) P. M. Enriquez-Navas et al. CANCER RESEARCH
- Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance
- (2015) Niels F. Jensen et al. Molecular Oncology
- The value of monitoring to control evolving populations
- (2015) Andrej Fischer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
- (2014) J. P. B. O'Connor et al. CLINICAL CANCER RESEARCH
- Sweat but no gain: Inhibiting proliferation of multidrug resistant cancer cells with “ersatzdroges”
- (2014) Yoonseok Kam et al. INTERNATIONAL JOURNAL OF CANCER
- Mathematical and computational models of drug transport in tumours
- (2014) C. M. Groh et al. Journal of the Royal Society Interface
- Evolution of acquired resistance to anti-cancer therapy
- (2014) Jasmine Foo et al. JOURNAL OF THEORETICAL BIOLOGY
- Evolutionary foundations for cancer biology
- (2013) C. Athena Aktipis et al. Evolutionary Applications
- Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers
- (2013) Sébastien Benzekry et al. JOURNAL OF THEORETICAL BIOLOGY
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantitative Imaging in Cancer Evolution and Ecology
- (2013) Robert A. Gatenby et al. RADIOLOGY
- Exploiting ecological principles to better understand cancer progression and treatment
- (2013) D. Basanta et al. Interface Focus
- Mechanisms and insights into drug resistance in cancer
- (2013) Hiba Zahreddine et al. Frontiers in Pharmacology
- The Role of Tumor Tissue Architecture in Treatment Penetration and Efficacy: An Integrative Study
- (2013) Katarzyna A. Rejniak et al. Frontiers in Oncology
- Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
- (2012) François-Clément Bidard et al. CANCER AND METASTASIS REVIEWS
- Evolutionary Approaches to Prolong Progression-Free Survival in Breast Cancer
- (2012) A. S. Silva et al. CANCER RESEARCH
- Exploiting Evolution To Treat Drug Resistance: Combination Therapy and the Double Bind
- (2012) David Basanta et al. MOLECULAR PHARMACEUTICS
- Cancer treatment as a game: integrating evolutionary game theory into the optimal control of chemotherapy
- (2012) Paul A Orlando et al. PHYSICAL BIOLOGY
- Evolutionary Dynamics in Cancer Therapy
- (2011) Jessica J. Cunningham et al. MOLECULAR PHARMACEUTICS
- Overlooking Evolution: A Systematic Analysis of Cancer Relapse and Therapeutic Resistance Research
- (2011) C. Athena Aktipis et al. PLoS One
- Optimization of Dosing for EGFR-Mutant Non-Small Cell Lung Cancer with Evolutionary Cancer Modeling
- (2011) J. Chmielecki et al. Science Translational Medicine
- Slow-Cycling Therapy-Resistant Cancer Cells
- (2011) Nathan Moore et al. STEM CELLS AND DEVELOPMENT
- A theoretical quantitative model for evolution of cancer chemotherapy resistance
- (2010) Ariosto S Silva et al. Biology Direct
- Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma
- (2010) M.-d.-M. Inda et al. GENES & DEVELOPMENT
- Metronomic chemotherapy: new rationale for new directions
- (2010) Eddy Pasquier et al. Nature Reviews Clinical Oncology
- Antibiotic resistance and its cost: is it possible to reverse resistance?
- (2010) Dan I. Andersson et al. NATURE REVIEWS MICROBIOLOGY
- Lessons from Applied Ecology: Cancer Control Using an Evolutionary Double Bind
- (2009) R. A. Gatenby et al. CANCER RESEARCH
- Adaptive Therapy
- (2009) R. A. Gatenby et al. CANCER RESEARCH
- A change of strategy in the war on cancer
- (2009) Robert A. Gatenby NATURE
- Re: Adaptive Therapy for Androgen-Independent Prostate Cancer: A Randomized Selection Trial of Four Regimens
- (2008) A. J. Armstrong et al. JNCI-Journal of the National Cancer Institute
- Modelling chemotherapy resistance in palliation and failed cure
- (2008) Helen C. Monro et al. JOURNAL OF THEORETICAL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation